Neil Kumar's Net Worth
$175 Million
Who is Neil Kumar?
Neil Kumar has an estimated net worth of $175 Million. This is based on reported shares across multiple companies, which include BridgeBio Pharma, Inc., LianBio, and Eidos Therapeutics, Inc..
SEC CIK
Neil Kumar's CIK is 0001742485
Past Insider Trading and Trends
2019 was Neil Kumar's most active year for acquiring shares with 9 total transactions. Neil Kumar's most active month to acquire stocks was the month of January. 2020 was Neil Kumar's most active year for disposing of shares, totalling 46 transactions. Neil Kumar's most active month to dispose stocks was the month of April. 2019 saw Neil Kumar paying a total of $55,005,574.52 for 10,938,629 shares, this is the most they've acquired in one year. In 2018 Neil Kumar cashed out on 16,285,176 shares for a total of $3,599,954.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BridgeBio Pharma, Inc. (BBIO) Snapshot price: $34.14
CEO and President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.61% | 29.92K |
$31.04 | -$954,417.92 | 4.9M |
May 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 12
| |||
Form 4
| +1.13% | 54.33K |
$37.21 | -$1,783,177.62 | 4.87M |
Feb 16
| |||
Form 4
|
—
|
0
|
$28.98 | -$2,963,152.94 | 4.81M |
Scheduled
|
Nov 16 - Nov 17
| ||
Form 4
|
—
|
0
|
$29.19 | -$2,984,584.44 | 4.81M |
Aug 16 - Aug 17
| |||
Form 4
|
—
|
0
|
$14.05 | -$1,436,538.47 | 4.81M |
May 16 - May 17
| |||
Form 4
| -10.59% | -120.00K |
$14.18 | -$1,701,744.00 | 1.01M |
May 3
| |||
Form 4
| -9.58% | -120.00K |
$15.46 | -$1,855,656.00 | 1.13M |
Apr 5
| |||
Form 4
| -8.74% | -120.00K |
$10.96 | -$1,315,224.00 | 1.25M |
Scheduled
|
Mar 3
| ||
Form 4
|
—
|
0
|
$12.68 | -$871,270.59 | 4.81M |
Scheduled
|
Feb 16 - Feb 17
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 4
| -8.04% | -120.00K |
$11.01 | -$1,320,696.00 | 1.37M |
Scheduled
|
Feb 3
| ||
Form 4
| -7.44% | -120.00K |
$7.67 | -$920,856.00 | 1.49M |
Scheduled
|
Jan 5
| ||
Form 4
| -16.73% | -200.00K |
—
|
—
| 1M |
Dec 21
| |||
Form 4
|
—
|
0
|
$9.52 | -$654,001.85 | 4.81M |
Nov 16 - Nov 17
| |||
Form 4
| +0.86% | 41.01K |
$11.08 | -$306,882.76 | 4.81M |
Aug 16
| |||
Form 4
| +0.95% | 44.95K |
$6.74 | -$160,135.66 | 4.77M |
May 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 16
| |||
Form 4
| +0.09% | 4.44K |
$8.84 | -$27,271.40 | 4.73M |
Feb 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 3
| |||
Form 4
| +0.08% | 3.79K |
$47.25 | -$176,242.50 | 4.72M |
Nov 16
| |||
Form 4
| +0.08% | 3.79K |
$49.48 | -$184,560.40 | 4.72M |
Aug 16
| |||
Form 4
| +0.08% | 3.79K |
$53.66 | -$200,205.46 | 4.72M |
May 16
| |||
Form 4
| +0.40% | 18.99K |
$63.74 | -$138,992.22 | 4.71M |
Feb 16 - Feb 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 4
| +0.07% | 3.35K |
$44.33 | -$78,641.42 | 4.69M |
Nov 16
| |||
Form 4
| +0.07% | 3.35K |
$28.53 | -$50,612.22 | 4.69M |
Aug 16
| |||
Form 4
| -3.69% | -80.00K |
$27.23 | -$2,178,066.07 | 2.09M |
Scheduled
|
Aug 3 - Aug 4
| ||
Form 4
| -6.21% | -143.47K |
$30.75 | -$4,411,357.06 | 2.17M |
Scheduled
|
Jul 1 - Jul 2
| ||
Form 4
| -0.46% | -10.60K |
$30.01 | -$318,125.08 | 2.31M |
Scheduled
|
Jun 8
| ||
Form 4
| -0.26% | -5.93K |
$30.05 | -$178,173.37 | 2.32M |
Scheduled
|
Jun 3
| ||
Form 4
| -3.33% | -80.00K |
$29.19 | -$2,335,389.61 | 2.33M |
Scheduled
|
Jun 1
| ||
Form 4
| -3.20% | -79.60K |
$31.02 | -$2,469,481.93 | 2.41M |
Scheduled
|
May 5
| ||
Form 4
| -3.13% | -80.40K |
$29.40 | -$2,364,085.00 | 2.48M |
Scheduled
|
May 1 - May 4
| ||
Form 4
| -0.07% | -1.80K |
$25.48 | -$45,983.10 | 2.57M |
Scheduled
|
Apr 7
| ||
Form 4
| -0.01% | -300.00 |
$25.09 | -$7,528.00 | 2.57M |
Scheduled
|
Apr 3
| ||
Form 4
| -2.94% | -77.89K |
$26.02 | -$2,026,465.64 | 2.57M |
Scheduled
|
Apr 1 - Apr 2
| ||
Form 4
| -4.34% | -120.00K |
$32.28 | -$3,874,030.43 | 2.65M |
Scheduled
|
Mar 2 - Mar 3
| ||
Form 4
| -1.10% | -30.89K |
$34.87 | -$1,077,390.29 | 2.77M |
Scheduled
|
Feb 5
| ||
Form 4
| -3.09% | -89.11K |
$34.70 | -$3,091,609.79 | 2.8M |
Scheduled
|
Feb 3 - Feb 4
| ||
Form 4
| -3.99% | -120.00K |
$32.52 | -$3,902,416.96 | 2.89M |
Scheduled
|
Jan 2 - Jan 3
| ||
Form 4
|
∞
| 8.95M |
—
|
—
| 8.95M |
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
LianBio (LIAN) Snapshot price: $4.11
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Eidos Therapeutics, Inc. No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +3.72% | 882.35K |
$29.90 | $26,382,795.88 | 24.58M |
Jul 3
| |||
Form 4
| +4.89% | 1.1M |
$25.93 | $28,622,778.64 | 23.69M |
May 24
| |||
Form 4
|
∞
| 19.61M |
$17.00 | $13,400,046.00 | 19.61M |
Jun 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||